ATE113468T1 - Verfahren zur trennung von teilchen nach grösse. - Google Patents

Verfahren zur trennung von teilchen nach grösse.

Info

Publication number
ATE113468T1
ATE113468T1 AT88906769T AT88906769T ATE113468T1 AT E113468 T1 ATE113468 T1 AT E113468T1 AT 88906769 T AT88906769 T AT 88906769T AT 88906769 T AT88906769 T AT 88906769T AT E113468 T1 ATE113468 T1 AT E113468T1
Authority
AT
Austria
Prior art keywords
particles
size
separation
tangential flow
liposomes
Prior art date
Application number
AT88906769T
Other languages
English (en)
Inventor
Robert P Lenk
Anthony G Durning
Robert J Klimchak
Joel Portnoff
Michelle L Tomsho
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26761847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE113468(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE113468T1 publication Critical patent/ATE113468T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B2227/00—Photographic printing apparatus
    • G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
    • G03B2227/325—Microcapsule copiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Devices And Processes Conducted In The Presence Of Fluids And Solid Particles (AREA)
AT88906769T 1987-07-29 1988-07-28 Verfahren zur trennung von teilchen nach grösse. ATE113468T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7930987A 1987-07-29 1987-07-29
US16458088A 1988-03-07 1988-03-07

Publications (1)

Publication Number Publication Date
ATE113468T1 true ATE113468T1 (de) 1994-11-15

Family

ID=26761847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88906769T ATE113468T1 (de) 1987-07-29 1988-07-28 Verfahren zur trennung von teilchen nach grösse.

Country Status (5)

Country Link
EP (1) EP0394265B1 (de)
JP (1) JP2877160B2 (de)
AT (1) ATE113468T1 (de)
DE (1) DE3852037T2 (de)
WO (1) WO1989000846A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
WO1994012155A1 (en) * 1992-12-02 1994-06-09 Vestar, Inc. Antibiotic formulation and process
US5958449A (en) * 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
CA2166465C (en) 1993-07-08 2003-10-14 Laura M. Edgerly-Pflug Method of controlling the size of liposomes
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
EP2198854B1 (de) 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Retardierte Freisetzung Liposomaler Anesthetischer Zusammensetzungen
ATE554748T1 (de) * 1997-11-14 2012-05-15 Pacira Pharmaceuticals Inc Herstellung von multivesikulären liposomen
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
FR2788780B1 (fr) * 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
AU2003262048A1 (en) * 2002-09-11 2004-04-30 Tanabe Seiyaku Co., Ltd. Process for the production of microspheres and unit therefor
CA2606440A1 (en) * 2005-04-29 2006-11-09 University Of Rochester Ultrathin porous nanoscale membranes, methods of making, and uses thereof
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
EA020753B1 (ru) 2008-06-16 2015-01-30 Бинд Терапьютикс, Инк. Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
ES2765240T3 (es) 2008-06-16 2020-06-08 Pfizer Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
ES2776126T3 (es) 2008-12-15 2020-07-29 Pfizer Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
GB0917003D0 (en) * 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
WO2011072218A2 (en) 2009-12-11 2011-06-16 Bind Biosciences Stable formulations for lyophilizing therapeutic particles
WO2011084513A2 (en) 2009-12-15 2011-07-14 Bind Biosciences, Inc. Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
EP2402075A1 (de) 2010-06-28 2012-01-04 Bühler AG Verfahren und Vorrichtung zur Herstellung von Vesikeln
CA2883703C (en) 2012-09-04 2021-10-19 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
PT2895156T (pt) 2012-09-17 2019-06-28 Pfizer Processo para a preparação de nanopartículas terapêuticas
SI3116547T1 (sl) 2014-03-14 2019-08-30 Pfizer, Inc. Terapevtski nanodelci, ki obsegajo terapevtsko stredstvo, in postopek izdelave ter uporabe le-teh
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
CN106456547B (zh) * 2014-07-02 2021-11-12 川斯勒佰尔公司 信使rna的包封
EP3773505A4 (de) * 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (de) 2021-10-14 2025-08-06 Pacira Pharmaceuticals Inc Bupivacain-multivesikuläre liposomformulierungen und verwendungen davon
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE8584T1 (de) * 1980-01-16 1984-08-15 Hans Georg Prof. Dr. Weder Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
US4420398A (en) * 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
US4888115A (en) * 1983-12-29 1989-12-19 Cuno, Incorporated Cross-flow filtration
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2576805B1 (fr) * 1985-02-01 1989-08-25 Lyonnaise Eaux Appareil de filtration tangentielle
GB2176715A (en) * 1985-06-27 1987-01-07 Apv Int Ltd Beer filtration
IL79985A0 (en) * 1985-09-13 1986-12-31 Ausimont Spa Purification of oils containing solid matter in suspension

Also Published As

Publication number Publication date
EP0394265A4 (en) 1991-07-31
EP0394265A1 (de) 1990-10-31
DE3852037D1 (de) 1994-12-08
JPH02504362A (ja) 1990-12-13
EP0394265B1 (de) 1994-11-02
WO1989000846A1 (en) 1989-02-09
JP2877160B2 (ja) 1999-03-31
DE3852037T2 (de) 1995-03-23

Similar Documents

Publication Publication Date Title
ATE113468T1 (de) Verfahren zur trennung von teilchen nach grösse.
DE69107855D1 (de) Verbessertes verfahren und vorrichtung zur tangentiellen filtrierung.
DE69132172D1 (de) Verfahren zur Abtrennung von Blutkomponenten aus Vollblut
DE69019690D1 (de) Verfahren zur Filtrierung und Reinigung von Wasser.
DE69107115D1 (de) Verfahren und Apparat zur Adsorptionsreinigung von zu destillierender Luft.
DE69218269D1 (de) Verfahren zur Herstellung von flüssigen Suspensionen aus Polysaccharidmischungen
ATE48086T1 (de) Verfahren und vorrichtung zur selektiven extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile.
DE69112197D1 (de) Verfahren zur Regeneration poröser keramischer Filter.
DE3687419D1 (de) Nichtgewobene stoffbahn, oel-wasser-trennungsfilter und verfahren zur oel-wasser-trennung.
ATE70366T1 (de) Magnetische teilchen zur verwendung in trennungen.
DE69106100D1 (de) Verfahren zur Trennung durch Adsorption und Adsorber.
DE3856587D1 (de) Vorrichtung und Verfahren zur Verminderung des Leukocytengehalts von Blutkomponenten
DE69020248D1 (de) Filtermaterial zum Abscheiden von Leukozyten und Verfahren zu seiner Herstellung.
DE59006656D1 (de) Verfahren zur Trennung und Rückgewinnung von Komponenten von Gemischen mittels Pervaporation.
DE69307962D1 (de) Verfahren zur Herstellung von Filterzigaretten
DE68918706D1 (de) Verfahren und vorrichtung zur trockenentfernung von verunreinigungen aus gasströmen.
DE69031481D1 (de) Verfahren zur Gewinnung von Ginkgoliden aus Ginkgoblättern und ihre Reinigung
AT383963B (de) Filter zur abtrennung von gasfoermigen oder fluessigen komponenten aus fluiden und verfahren zu dessen herstellung
DE3486207D1 (de) Verfahren zur Abtrennung von 2-Chlor-m-xylol.
AT377709B (de) Filterapparat zur abtrennung von feststoffen aus fluessigkeiten
DE69010083D1 (de) Kontinuierliches Verfahren zur Trennung von teils in wasserlöslichen Bestandteilen aus einem Schlamm.
DE58906335D1 (de) Verfahren zur Modifizierung von cellulosischen Dialysemembranen zur Verbesserung der Biocompatibilität und Vorrichtung zur Durchführung des Verfahrens.
DE3650268D1 (de) Glutamatcopolymer enthaltendes optisches Filter und Verfahren zur Herstellung eines Glutamatcopolymer enthaltenden optischen Filters.
DE68902058D1 (de) Verfahren zur extrakorporalen behandlung von ascites-fluessigkeit.
DE69111637D1 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time